{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory&page=5", "query": { "condition": "Inflammatory", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 216, "total_pages": 22, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inflammatory&page=4&page_size=10" }, "source": "local", "last_synced_at": "2026-10-16T20:55:20.954Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05656378", "title": "A Repository to Study Host-Microbiome Interactions in Health and Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy Controls", "Inflammatory Diseases", "Pediatric Illnesses", "Pregnancy" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 600, "start_date": "2023-03-09", "completion_date": "2032-01-01", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-16T06:34:13.983Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05656378" }, { "nct_id": "NCT03813862", "title": "Observational Pharmaco-Epidemiology Research & Analysis", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiovascular Diseases", "Chronic Disease", "HIV/AIDS", "Inflammatory Bowel Diseases", "Liver Diseases", "Neurodegenerative Diseases", "Rheumatic Diseases" ], "interventions": [ { "name": "Non-interventional (observational only)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Epividian", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "0 Years", "maximum_age": null, "sex": "ALL", "summary": "0 Years and older" }, "enrollment_count": 2000000, "start_date": "2013-12-01", "completion_date": "2035-11", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-10-16T20:55:20.954Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03813862" }, { "nct_id": "NCT07085104", "title": "A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Idiopathic Inflammatory Myopathy", "Systemic Lupus Erythematosus (With and Without Nephritis)", "Systemic Sclerosis" ], "interventions": [ { "name": "ALLO-329", "type": "GENETIC" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" } ], "intervention_types": [ "GENETIC", "DRUG" ], "sponsor": "Allogene Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 66, "start_date": "2025-11-13", "completion_date": "2032-10", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-10-03T00:17:00.355Z", "location_count": 16, "location_summary": "Phoenix, Arizona • Loma Linda, California • Aurora, Colorado + 13 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Loma Linda", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07085104" }, { "nct_id": "NCT06339177", "title": "Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hyperinflammatory Syndromes", "Lymphohistiocytosis, Hemophagocytic", "Macrophage Activation Syndrome", "Secondary Hemophagocytic Lymphohistiocytosis" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 300, "start_date": "2024-07-02", "completion_date": "2031-04-01", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-10-14T22:46:59.882Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Pittsburgh, Pennsylvania", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06339177" }, { "nct_id": "NCT07612267", "title": "A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Inflammatory Bowel Disease", "Lactation" ], "interventions": [ { "name": "Mirikizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Weeks", "maximum_age": null, "sex": "FEMALE", "summary": "3 Weeks and older · Female only" }, "enrollment_count": 14, "start_date": "2026-08-05", "completion_date": "2028-09", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-10-14T10:00:52.735Z", "location_count": 5, "location_summary": "Glenview, Illinois • Iowa City, Iowa • Baltimore, Maryland + 2 more", "locations": [ { "city": "Glenview", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Utica", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07612267" }, { "nct_id": "NCT07800871", "title": "FT839 in Autoimmune Diseases", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "ANCA-Associated Vasculitis (AAV)", "Idiopathic Inflammatory Myositis (IIM)", "Rheumatoid Arthritis (RA)", "Systemic Lupus Erythematosus (SLE)", "Systemic Sclerosis (SSc)" ], "interventions": [ { "name": "FT839", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Fate Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 446, "start_date": "2026-10", "completion_date": "2040-10", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-10-05T00:03:12.131Z", "location_count": 1, "location_summary": "Fullerton, California", "locations": [ { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07800871" }, { "nct_id": "NCT07791862", "title": "Familial Inflammatory Bowel Disease Early Risk", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Crohn Disease (CD)", "Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)", "Ulcerative Colitis (UC)" ], "interventions": [], "intervention_types": [], "sponsor": "Seattle Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "0 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "0 Years to 55 Years" }, "enrollment_count": 7000, "start_date": "2026-03-26", "completion_date": "2036-02", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-08-30T00:48:51.964Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT07791862" }, { "nct_id": "NCT04278404", "title": "Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Adrenal Insufficiency", "Arrythmia", "Asthma in Children", "Attention Deficit Hyperactivity Disorder", "Bronchopulmonary Dysplasia", "Coagulation Disorder", "Coronavirus Infection (COVID-19)", "Down Syndrome", "Edema", "Fibrinolysis; Hemorrhage", "Heart Failure", "Hemophilia", "Hyperphosphatemia", "Hypertension", "Hypokalemia", "Insomnia", "Kawasaki Disease", "Menorrhagia", "Multisystem Inflammatory Syndrome in Children (MIS-C)", "Pain", "Pneumonia", "Primary Hyperaldosteronism", "Pulmonary Arterial Hypertension", "Skin Infection", "Urinary Tract Infections in Children" ], "interventions": [ { "name": "The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "0 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "0 Years to 20 Years" }, "enrollment_count": 5000, "start_date": "2020-03-05", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-15T18:21:51.007Z", "location_count": 49, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 40 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04278404" }, { "nct_id": "NCT06274554", "title": "Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Crohn's Disease", "Inflammatory Bowel Diseases" ], "interventions": [ { "name": "Fluconazole", "type": "DRUG" }, { "name": "IL-23 Therapy", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2024-10-04", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-10-03T00:10:54.189Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06274554" }, { "nct_id": "NCT04567771", "title": "Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cervical Carcinoma", "Endometrial Carcinoma", "Endometriosis", "Pelvic Inflammatory Disease" ], "interventions": [ { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "OTHER", "RADIATION" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 121, "start_date": "2020-12-04", "completion_date": "2029-04-01", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-14T20:58:58.486Z", "location_count": 3, "location_summary": "Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04567771" } ] }